Quality of life in patients with glioblastoma participating in a randomized study of boost brachytherapy

Abstract

Future studies in patients harboring malignant gliomas must incorporate measures assessing QOL because traditional measures focusing on physical or neurological functioning give an incomplete assessment of the patient's experience.